 SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 GLOBE NEWSWIRE -- CareDx, Inc. Nasdaq: CDNA The Transplant CompanyTM focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients today announced it will report financial results for the fourth quarter and full year 2021 after market close on Thursday, February 24, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time 4:30 p.m. Eastern Time. 